MCC Imaging Metrics Steering Committee to present draft metrics at DIA Medical Imaging meeting ...

[Steering Committee letter] [draft metrics]

 

 

 

 

 

 

DIA Conference: MEDICAL IMAGING CONTINUUM - Path Forward for Advancing the Uses of Medical Imaging in the Development of New Biopharmaceutical Products [Oct 2 - 3 2008 Bethesda, MD ]

 

THURSDAY • OCTOBER 2

 

METRICS SESSION 1 - QUANTIFYING QUALITY

CHAIRPERSON: David Rauh CDS Imaging Coordinator, Eli Lilly and Company

·         Overview of the Metrics Champion Consortium (MCC): History and Methodology [slides]

David Rauh

CDS Imaging Coordinator, Eli Lilly and Company

 

·         Operations WG on Metrics Characterizing the Execution of Clinical Trials, Logistics [slides]

Antoinette A. Chan, PhD

Manager, Medical Imaging Technical Services, Amgen, Inc.

 

Kevin Jaynes

Program Director, Perceptive Informatics

 

·         Outsourcing Performance Metrics Working Group [slides]

Dawn E. Flitcraft, CNMT, RDMS

Vice President, Client Services, Bio-Imaging Technologies, Inc.

 

·         Clinical WG on Metrics Characterizing Central Image Acquisition and Analysis [slides]

Helen Young, PhD

Senior Imaging Scientist and Imaging Capability Leader, AstraZeneca

 

James J. Conklin, MS, MD

Senior Vice President, Medical & Scientific Affairs, ICON Medical Imaging

 

·         Group Discussion on Nominations for Metrics

---

MCC Imaging Performance Metrics Steering Committee Seeking Imaging Work Group Participants 

We would like to invite you and your colleagues to participate in the new MCC Imaging Performance Metrics initiative. Our goal for this initiative is to:

·     Develop metrics to improve all aspects of clinical trial imaging including sponsor, core lab and site processes. Metrics should be developed for the purpose of identifying “what works” and “what needs improvement”.

·     Provide the ability to utilize metric data as an information and discussion tool for sponsor and core lab decision makers; drive change as appropriate.

This initiative will provide Sponsors and Imaging Labs a baseline set of metrics with a clear explanation of what the metrics mean, how they are derived and how each company can use the metrics to improve efficiency. This will not only eliminate the effort put forth by sponsors to develop, understand and review Imaging performance metrics from multiple Imaging Labs, it will also enable productivity enhancements for the Imaging Labs by allowing them to produce one set of metrics across sponsors (instead of having sponsor-specific metrics which differ from sponsor to sponsor).

As an effort to begin the Imaging Metrics Initiative, the Imaging Performance Metrics Steering Committee would like to identify individuals from your company to participate in working groups.  Our goal is to begin working group meetings in early March.  Initially, three working groups are being created to drive this initiative forward:

            Clinical Working Group:  clinical/technical based metrics (ex: reader variability, adjudication, etc…)

Operations Working Group:  study operations metrics reflecting sponsor, core lab and site performance (ex:  image receipt turnaround time, image quality, image processing, etc…)

Outsourcing Working Group: outsourcing, financial metrics (ex:  RFP process, study financial metrics, change orders, etc…)

Please note that any given individual may participate in one or more working groups.  In addition, multiple individuals from the same company may participate in a single working group.

 

We look forward to working with all of you on this important initiative and hope you will decide to join a MCC Imaging Performance Metrics work group. For additional information about the MCC Imaging Metrics Initiative, please see the MCC Imaging Metrics brief.  Please complete the online work group application form  or contact Linda Sullivan if you are interested in joining a work group.

 

Thank you,

 

MCC Imaging Steering Committee  

David Rauh	Eli Lilly (Chair)
Antoinette A. Chan, PhD	Amgen
Helen Young, PhD	AstraZeneca
Dawn Flitcraft	Bio-Imaging Technologies, Inc.
Jane Gale, PhD	Bristol-Myers Squibb
Ciaran Mark Cooper	m2s
Lewis Cohen, MD	Medarex
David Mozley, MD	Merck
Kevin Jaynes	Perceptive Informatics
Craig Lipset	Pfizer
Robert Ford, MD	RadPharm

Work group participants must be employed by a MCC Corporate Sponsor or Member organization. Information about becoming a MCC Corporate Sponsor or Member is available [View Membership Benefits].